Laurent Audoly PhD, CEO Of Kymera Therapeutics Discusses E3 Ligase Atlas In Development.
Browsing: News
Rena Feinman, PhD Associate Scientist, Department of Research, John Theurer Cancer Center at Hackensack University Medical Center Discusses The Microboime…
Michelle Dawson Franchise Head Hematology, US Medical Affairs at AstraZeneca Discusses AstraZeneca The Leader In Hematology At The 60th ASH…
Scott Fields, M.D., SVP Head Pharmaceutical Development Oncology at Bayer Pharmaceuticals discusses Bayer Xofigo Program. At ESMO Oncology Conference -…
Scott Fields, M.D., SVP Head Pharmaceutical Development Oncology at Bayer Pharmaceuticals discusses Bayer Stivarga Program. At ESMO Oncology Conference -…
Scott Fields, M.D., SVP Head Pharmaceutical Development Oncology at Bayer Pharmaceuticals discusses Bayer Regorafenib Program. At ESMO Oncology Conference -…
Scott Fields, M.D., SVP Head Pharmaceutical Development Oncology at Bayer Pharmaceuticals discusses Bayer Copanlisib Program. At ESMO Oncology Conference -…
Scott Fields, M.D., SVP Head Pharmaceutical Development Oncology at Bayer Pharmaceuticals discusses Bayer Larotrectinib Program. At ESMO Oncology Conference -…
Scott Fields, M.D., SVP Head Pharmaceutical Development Oncology at Bayer Pharmaceuticals discusses Whats on The Horizon For Bayer Pharmaceuticals. At…
Scott Fields, SVP Head Pharmaceutical Development Oncology at Bayer Pharmaceuticals discusses Larotrectinib, Xofigo, Copanlisib, & Regorafenib Research. At ESMO Oncology…
Scott Fields, SVP Head Pharmaceutical Development Oncology at Bayer Pharmaceuticals discusses Treatment With Xofigo, Abiraterone, & Copanlisib. At ESMO Oncology…
Thomas Helleday, Phd, Helleday Laboratory, Discusses Using Mutational Signatures To Tailor New Treatments. At ESMO Oncology Conference – Munich, Germany…
Francis J. McGovern, MD explains the need to Educate to Patients to Only Take What is Needed | Pain Level…
Francis J. McGovern, MD explains Blocking Inflammatory Pain Pathway | Anesthetic Depends on Expertise of Anesthesiologist at AACR 2018
Francis J. McGovern, MD explains the Perioperative Opioid-Sparing Analgesia Strategies for Enhanced Recovery after Urologic Surgery at AACR 2018
Jon Eckard, MD, TYME Inc., explains Explosion of Development Over Last 5-10 Years | Focus on the Patients Not Just…
Petros Grivas, MD, PhD, University of Washington talks about Academic & Community Oncologists Must Collaborate | Accrue Trials to Develop…
Eric A. Klein, MD, Cleveland Clinic explains No Good Screening Tests for Several Cancers | Able to See Early Signals…
Eric A. Klein, MD, Cleveland Clinic, explains Tumor Cells Shed DNA & RNA | Technology Is Powerful Enough to Find…
Eric A. Klein, MD, Cleveland Clinic, Preliminary Look at 10% of 15,000 Participants | Not Ready to be Applied to…
Eric A. Klein, MD, Cleveland Clinic, explains how Test Must Have High Specificity | False-Positive Rate Must be Extraordinarily Low…
Liviu Niculescu, MD PhD, explains How To Make Sense of the Amount of Information Focus on the Most Important Data…
Rafael G Amado, MD, Adaptimmune, LLC, explains Engineer T-Cell Receptors, Affinity Matured Can recognize and kill tumor cells at Annual…
Jon Eckard, PhD, TYME Inc., explains Patients Tired of Toxic Chemotherapies Current data shows efficacy & maintaining quality of life…
Rafael G Amado, MD, Adaptimmune, LLC, explains Expanding Cohorts of Patients to Verify Results Increase number of cells & intensity…
Jon Eckard, PhD, TYME Inc., explains Studies Today are Focused on Biomarkers Not Biomarker specific, broad efficacy at Annual Meeting…
Jon Eckard, PhD, TYME Inc., talks about Four Drug Combination – effects driven by one drug With other drugs supplementing…
Rafael G Amado, MD, Adaptimmune, LLC, explains Between 1-5 Billion Cells Given to Patients Cytokine Release Syndrome resolved with antiIL-6…
Ahmad Tarhini, MD, PhD, Cleveland Clinic Main Campus, talks about Data is Hypothesis-Generating Data is still useful for determining optimal…
Chuck Wiseman, MD, BriaCell Therapeutics, discusses Capitalizing on Matching HL-Antigens Key to developing clinically relevant immune response at Annual Meeting…
Dr. Meletios A. Dimopoulos, MD, National and Kapodistrian University of Athens, explains BTK Inhibitors Associated with Atrial Fibrillation Only 4%…
Dr. Meletios A. Dimopoulos, MD, National and Kapodistrian University of Athens, explains Ibrutinib & Rituximab is a new standard for…
Jinghui Zhang, PhD, St. Jude Children’s Research Hospital, explains Genome Sequencing Enable a Complete Picture Additional analyses not found on…
Chinthalapally V. Rao, PhD, Stephenson Cancer Center, talks about Marginal Beneficial Effects After 6 Months to 1 Year Limitations of…
Jinghui Zhang, PhD, St. Jude Children’s Research Hospital, explains Researchers Upload Data With St. Jude Cloud Goal is to Enable…
Scott Newman, PhD, St. Jude Children’s Research Hospital, explains What is St. Jude Cloud? Bring tools to the data &…
Jinghui Zhang, PhD, St. Jude Children’s Research Hospital, explains Access, Analyze, & Visualize Genomic Data Offer 5,000 Genome sequencing datasets…
Chinthalapally V. Rao, PhD, Stephenson Cancer Center, talks about Aspirin Prevents Colorectal Cancer Progress Patients subconsciously taking aspirin may cause…
Paul A. Northcott, PhD, St. Jude Children’s Research Hospital, explains Examples of Genes Activated by Enhancer Hijacking Validate findings based…
Scott Newman, PhD, St. Jude Children’s Research Hospital, explains St. Jude Cloud Reanalyzed coding variants Some B-Cell ALL have mutational…
Jinghui Zhang, PhD, St. Jude Children’s Research Hospital, explains Cloud-Computing – Centralized Infrastructure Enables access of data for all research…
Paul A. Northcott, PhD, St. Jude Children’s Research Hospital, explains Linking Aberrations to Oncogene De-Regulation Unable to make 1-to-1 correlation…
Timothy Yap, MBBS, Ph.D., MD Anderson Cancer Center, talks about MD Anderson Provides Screenings for Therapies Reviewed by Precision Oncology…
Elaine R. Mardis, PhD, The Institute for Genomic Medicine, talks about Next Meeting will Showcase Modern Technology Next generation sequencing…
Paul A. Northcott, PhD, St. Jude Children’s Research Hospital, explains Novel Mechanisms of Oncogene De-Regulation Integrative Genomic Approaches to implicate…
Timothy Yap, MBBS, Ph.D., MD Anderson Cancer Center, talks about Understanding Intratumor Heterogeneity Founding ubiquitous mutations vs. heterogeneous events at…
Emily L. Harris, Ph.D., M.P.H., National Cancer Institute – Deputy Associate Director, explains Three Main Data Sharing Policies Large Budget…
Timothy Yap, MBBS, Ph.D., MD Anderson Cancer Center, talks about Abnormalities With Next-Gen Sequencing Widen therapeutic options by tailoring trials…
Elaine R. Mardis, PhD, The Institute for Genomic Medicine, explains 80% of Patients Don’t go to Tertiary Centers Making sure…
Emily L. Harris, Ph.D., M.P.H.,National Cancer Institute – Deputy Associate Director, explains NIH Data Sharing Accelerates Research Progress Sharing broadly…